Noradrenergic and specific serotonergic antidepressant
Class of antidepressants
Overview[edit | edit source]
Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of antidepressant drugs that are primarily used in the treatment of major depressive disorder (MDD). NaSSAs are known for their unique mechanism of action, which involves modulating the activity of both norepinephrine and serotonin neurotransmitters in the brain. This dual action is thought to contribute to their efficacy in alleviating depressive symptoms.
Mechanism of Action[edit | edit source]
NaSSAs work by antagonizing specific serotonin receptors (such as 5-HT2 and 5-HT3) and alpha-2 adrenergic receptors. By blocking these receptors, NaSSAs increase the release of norepinephrine and serotonin, enhancing neurotransmission in pathways that are often underactive in depression. This mechanism is distinct from that of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which primarily inhibit the reuptake of serotonin and norepinephrine.
Clinical Use[edit | edit source]
NaSSAs are primarily prescribed for the treatment of major depressive disorder, particularly in patients who may not respond well to other classes of antidepressants. They are also sometimes used off-label for conditions such as anxiety disorders, insomnia, and post-traumatic stress disorder (PTSD).
Side Effects[edit | edit source]
Common side effects of NaSSAs include sedation, increased appetite, and weight gain. These effects are largely due to the antihistaminergic properties of the drugs. Unlike SSRIs and SNRIs, NaSSAs are less likely to cause sexual dysfunction, which can be a significant advantage for some patients.
Examples[edit | edit source]
The most well-known NaSSA is mirtazapine, which is widely used in clinical practice. Mirtazapine is often chosen for its sedative properties, which can be beneficial for patients with insomnia associated with depression.
Pharmacokinetics[edit | edit source]
NaSSAs are typically administered orally and have a relatively long half-life, allowing for once-daily dosing. They are metabolized in the liver and excreted primarily through the kidneys.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
